HERBALIFE LTD (HLF) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:HLF • KYG4412G1010

16.56 USD
-0.11 (-0.66%)
At close: Feb 11, 2026
16.45 USD
-0.11 (-0.66%)
After Hours: 2/11/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

HLF gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. While HLF belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. HLF may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • HLF had positive earnings in the past year.
  • HLF had a positive operating cash flow in the past year.
  • HLF had positive earnings in each of the past 5 years.
  • In the past 5 years HLF always reported a positive cash flow from operatings.
HLF Yearly Net Income VS EBIT VS OCF VS FCFHLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

  • HLF has a better Return On Assets (11.89%) than 86.11% of its industry peers.
  • The Return On Invested Capital of HLF (25.82%) is better than 94.44% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HLF is significantly above the industry average of 11.63%.
  • The last Return On Invested Capital (25.82%) for HLF is above the 3 year average (21.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.89%
ROE N/A
ROIC 25.82%
ROA(3y)8.71%
ROA(5y)10.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)21.47%
ROIC(5y)23.4%
HLF Yearly ROA, ROE, ROICHLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

  • With a decent Profit Margin value of 6.46%, HLF is doing good in the industry, outperforming 69.44% of the companies in the same industry.
  • HLF's Profit Margin has declined in the last couple of years.
  • With a decent Operating Margin value of 12.61%, HLF is doing good in the industry, outperforming 77.78% of the companies in the same industry.
  • In the last couple of years the Operating Margin of HLF has declined.
  • HLF has a better Gross Margin (77.96%) than 88.89% of its industry peers.
  • In the last couple of years the Gross Margin of HLF has remained more or less at the same level.
Industry RankSector Rank
OM 12.61%
PM (TTM) 6.46%
GM 77.96%
OM growth 3Y-9.16%
OM growth 5Y-4.06%
PM growth 3Y-12.9%
PM growth 5Y-4.4%
GM growth 3Y-0.32%
GM growth 5Y-0.62%
HLF Yearly Profit, Operating, Gross MarginsHLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HLF is creating value.
  • Compared to 1 year ago, HLF has more shares outstanding
  • The number of shares outstanding for HLF has been reduced compared to 5 years ago.
  • The debt/assets ratio for HLF has been reduced compared to a year ago.
HLF Yearly Shares OutstandingHLF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
HLF Yearly Total Debt VS Total AssetsHLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.62 indicates that HLF is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.62, HLF is doing good in the industry, outperforming 61.11% of the companies in the same industry.
  • HLF has a debt to FCF ratio of 9.30. This is a negative value and a sign of low solvency as HLF would need 9.30 years to pay back of all of its debts.
  • The Debt to FCF ratio of HLF (9.30) is better than 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.3
Altman-Z 2.62
ROIC/WACC3.39
WACC7.62%
HLF Yearly LT Debt VS Equity VS FCFHLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

  • A Current Ratio of 1.11 indicates that HLF should not have too much problems paying its short term obligations.
  • HLF has a Current ratio of 1.11. This is in the lower half of the industry: HLF underperforms 75.00% of its industry peers.
  • HLF has a Quick Ratio of 1.11. This is a bad value and indicates that HLF is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HLF has a worse Quick ratio (0.59) than 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.59
HLF Yearly Current Assets VS Current LiabilitesHLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • HLF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.51%, which is quite good.
  • The Earnings Per Share has been decreasing by -7.08% on average over the past years.
  • Looking at the last year, HLF shows a decrease in Revenue. The Revenue has decreased by -0.78% in the last year.
  • HLF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.47% yearly.
EPS 1Y (TTM)8.51%
EPS 3Y-25.39%
EPS 5Y-7.08%
EPS Q2Q%-12.28%
Revenue 1Y (TTM)-0.78%
Revenue growth 3Y-4.89%
Revenue growth 5Y0.47%
Sales Q2Q%2.69%

3.2 Future

  • HLF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.64% yearly.
  • HLF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.48% yearly.
EPS Next Y8.88%
EPS Next 2Y16.16%
EPS Next 3Y21.64%
EPS Next 5YN/A
Revenue Next Year0.38%
Revenue Next 2Y1.67%
Revenue Next 3Y2.48%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HLF Yearly Revenue VS EstimatesHLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
HLF Yearly EPS VS EstimatesHLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

9

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.12 indicates a reasonable valuation of HLF.
  • Compared to the rest of the industry, the Price/Earnings ratio of HLF indicates a rather cheap valuation: HLF is cheaper than 91.67% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.18, HLF is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 6.26, the valuation of HLF can be described as very cheap.
  • 91.67% of the companies in the same industry are more expensive than HLF, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.01, HLF is valued rather cheaply.
Industry RankSector Rank
PE 8.12
Fwd PE 6.26
HLF Price Earnings VS Forward Price EarningsHLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 88.89% of the companies in the same industry are more expensive than HLF, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLF indicates a rather cheap valuation: HLF is cheaper than 91.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.88
EV/EBITDA 4.59
HLF Per share dataHLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • HLF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HLF has a very decent profitability rating, which may justify a higher PE ratio.
  • HLF's earnings are expected to grow with 21.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.91
PEG (5Y)N/A
EPS Next 2Y16.16%
EPS Next 3Y21.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HLF!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HERBALIFE LTD

NYSE:HLF (2/11/2026, 8:04:00 PM)

After market: 16.45 -0.11 (-0.66%)

16.56

-0.11 (-0.66%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-05
Earnings (Next)02-18
Inst Owners101.76%
Inst Owner Change-3.38%
Ins Owners1.97%
Ins Owner Change-0.85%
Market Cap1.71B
Revenue(TTM)4.96B
Net Income(TTM)320.70M
Analysts77.5
Price Target14.79 (-10.69%)
Short Float %9.84%
Short Ratio4.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.05%
Min EPS beat(2)7.39%
Max EPS beat(2)52.72%
EPS beat(4)4
Avg EPS beat(4)45.38%
Min EPS beat(4)7.39%
Max EPS beat(4)62.26%
EPS beat(8)7
Avg EPS beat(8)36.5%
EPS beat(12)9
Avg EPS beat(12)26.94%
EPS beat(16)12
Avg EPS beat(16)24.34%
Revenue beat(2)0
Avg Revenue beat(2)-1.18%
Min Revenue beat(2)-1.94%
Max Revenue beat(2)-0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)0.12%
Revenue beat(8)2
Avg Revenue beat(8)-1.1%
Revenue beat(12)6
Avg Revenue beat(12)0.05%
Revenue beat(16)7
Avg Revenue beat(16)-0.09%
PT rev (1m)20.83%
PT rev (3m)55.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.08%
EPS NY rev (1m)0.8%
EPS NY rev (3m)0.91%
Revenue NQ rev (1m)-0.32%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 8.12
Fwd PE 6.26
P/S 0.34
P/FCF 7.88
P/OCF 5.62
P/B N/A
P/tB N/A
EV/EBITDA 4.59
EPS(TTM)2.04
EY12.32%
EPS(NY)2.64
Fwd EY15.97%
FCF(TTM)2.1
FCFY12.68%
OCF(TTM)2.95
OCFY17.8%
SpS48.03
BVpS-5.92
TBVpS-9.96
PEG (NY)0.91
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 11.89%
ROE N/A
ROCE 36.85%
ROIC 25.82%
ROICexc 31.48%
ROICexgc 44.93%
OM 12.61%
PM (TTM) 6.46%
GM 77.96%
FCFM 4.37%
ROA(3y)8.71%
ROA(5y)10.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)21.47%
ROIC(5y)23.4%
ROICexc(3y)31.31%
ROICexc(5y)37.76%
ROICexgc(3y)50.31%
ROICexgc(5y)62.7%
ROCE(3y)30.65%
ROCE(5y)33.4%
ROICexgc growth 3Y-11.83%
ROICexgc growth 5Y-10.42%
ROICexc growth 3Y-12.15%
ROICexc growth 5Y-7.63%
OM growth 3Y-9.16%
OM growth 5Y-4.06%
PM growth 3Y-12.9%
PM growth 5Y-4.4%
GM growth 3Y-0.32%
GM growth 5Y-0.62%
F-Score7
Asset Turnover1.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.3
Debt/EBITDA 2.68
Cap/Depr 72.46%
Cap/Sales 1.77%
Interest Coverage 250
Cash Conversion 40.81%
Profit Quality 67.66%
Current Ratio 1.11
Quick Ratio 0.59
Altman-Z 2.62
F-Score7
WACC7.62%
ROIC/WACC3.39
Cap/Depr(3y)118.39%
Cap/Depr(5y)121.51%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.55%
Profit Quality(3y)93.92%
Profit Quality(5y)97.9%
High Growth Momentum
Growth
EPS 1Y (TTM)8.51%
EPS 3Y-25.39%
EPS 5Y-7.08%
EPS Q2Q%-12.28%
EPS Next Y8.88%
EPS Next 2Y16.16%
EPS Next 3Y21.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.78%
Revenue growth 3Y-4.89%
Revenue growth 5Y0.47%
Sales Q2Q%2.69%
Revenue Next Year0.38%
Revenue Next 2Y1.67%
Revenue Next 3Y2.48%
Revenue Next 5YN/A
EBIT growth 1Y48.57%
EBIT growth 3Y-13.6%
EBIT growth 5Y-3.61%
EBIT Next Year38.49%
EBIT Next 3Y15.75%
EBIT Next 5YN/A
FCF growth 1Y25.8%
FCF growth 3Y-19.13%
FCF growth 5Y-14.2%
OCF growth 1Y-3.3%
OCF growth 3Y-14.73%
OCF growth 5Y-9.01%

HERBALIFE LTD / HLF FAQ

Can you provide the ChartMill fundamental rating for HERBALIFE LTD?

ChartMill assigns a fundamental rating of 6 / 10 to HLF.


What is the valuation status for HLF stock?

ChartMill assigns a valuation rating of 9 / 10 to HERBALIFE LTD (HLF). This can be considered as Undervalued.


What is the profitability of HLF stock?

HERBALIFE LTD (HLF) has a profitability rating of 7 / 10.


What are the PE and PB ratios of HERBALIFE LTD (HLF) stock?

The Price/Earnings (PE) ratio for HERBALIFE LTD (HLF) is 8.12 and the Price/Book (PB) ratio is -2.8.


What is the earnings growth outlook for HERBALIFE LTD?

The Earnings per Share (EPS) of HERBALIFE LTD (HLF) is expected to grow by 8.88% in the next year.